<DOC>
	<DOCNO>NCT01033955</DOCNO>
	<brief_summary>Study Design : A , multinational , double blind , placebo-controlled pilot RCT involve 80 patient general ICUs 30 centre . Most patient recruit within Canada ; however case recruit international site . This study conduct auspex Canadian Critical Care Trials Group ( CCCTG ) International Forum Acute Care Trialists ( InFACT ) .</brief_summary>
	<brief_title>Collaborative H1N1 Adjuvant Treatment Pilot Trial</brief_title>
	<detailed_description>Primary Objective : The primary objective CHAT Pilot Trial ass ability recruit desire patient population ( i.e. , proportion eligible patient enrol trial ) , conduct scientifically rigorous international RCT pandemic circumstance . Secondary Objectives : To evaluate ( ) adherence medication administration regimen . ( ii ) ability research staff collect require primary secondary endpoint plan full CHAT trial , ( iii ) number study withdrawal due administration open-label statin withdrawal consent ( iv ) impact approve consent model recruitment rate . Study Methods ( Overview ) : Using web-based randomization system patient , research coordinator assign critically ill adult treat antiviral medication &lt; equal 72 hour require mechanical ventilation one two treatment strategy ( rosuvastatin placebo ) 14 day . Given need recruit patient CHAT Trial pandemic condition , family member may present provide write informed consent , request either waiver consent defer consent Research Ethics Boards ( REBs ) participate centre . The Keenan Research Centre/Li Ka Shing Knowledge Institute ( St Michael 's Hospital , Toronto , Ontario ) study Methods Centre .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Critically ill adult patient &gt; equal 16 year age admit adult ICU reason suspect , probable confirm influenza infection 2 . Requiring mechanical ventilation ( invasive noninvasive ) 3 . Receiving antiviral therapy ( medication dose intended duration ) &lt; equal 72 hour 4 . Attending physician intensivist must 'moderate ' 'high ' index suspicion influenza 1 . Age &lt; 16 year 2 . Do resuscitate reintubate order documented chart anticipate withdrawal life support 3 . Weight &lt; 40 kg 4 . Unable receive unlikely absorb enteral study drug ( e.g . incomplete complete bowel obstruction , intestinal ischemia , infarction , short bowel syndrome ) 5 . Rosuvastatin specific exclusion : Already receive statin ( Atorvastatin , Lovastatin , Simvastatin , Pravastatin , Rosuvastatin ) Allergy intolerance statin Receiving niacin , fenofibrate , cyclosporine , gemfibrozil , lopinavir , ritonavir plan use oral contraceptive estrogen therapy ICU stay CK exceed 10 time ULN ALT exceed 8 time ULN 6 . Severe chronic liver disease ( ChildPugh Score 1115 ) 7 . Previous enrollment trial 8 . Pregnancy breast feed 9 . At time enrollment , patient must receive &gt; 72 hour antiviral therapy</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>critical care</keyword>
	<keyword>H1N1/influenza infection</keyword>
	<keyword>respiration</keyword>
	<keyword>ventilation , artificial</keyword>
	<keyword>critically ill patient</keyword>
	<keyword>invasive mechanical ventilation</keyword>
	<keyword>H1N1/influenza infection ( suspect , probable confirm )</keyword>
</DOC>